BDBM684399 US20240218021, Example 296::US20240218021, Example 298

SMILES CC[C@H](NC(=O)[C@@H]1N[C@@H](F)CC1C(=O)C1(CC1)C(F)(F)F)C(=O)N[C@H]1CCCCNC(=O)[C@@H](C)NC(=O)[C@H](Cc2cc(Cl)ccc2Cl)N(C)C(=O)[C@H](CC(C)C)NC1=O

InChI Key InChIKey=OHSKLFBSHQPBTF-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 684399   

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandPNGBDBM684399(US20240218021, Example 296 | US20240218021, Exampl...)
Affinity DataIC50: 120nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Circle Pharma

US Patent
LigandPNGBDBM684399(US20240218021, Example 296 | US20240218021, Exampl...)
Affinity DataIC50: 110nMAssay Description:FP binding assays were performed in 25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT, 0.01% NP-40 and 1 mg/mL BSA for all 3 protein complexes in black 96-we...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2024
Entry Details
US Patent